Skip to main content

Table 2 Six month amputation rate by Rutherford class

From: The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design

 

AMP

Tot

% AMP

p *

All Pts

15

48

31.3%

 

R4

1

18

5.6%

0.0029

R5

14

30

46.7%

 

BMAC

10

34

29.4%

 

R4

1

11

9.1%

0.0721

R5

9

23

39.1%

 

Control

5

14

35.7%

 

R4

0

7

0.0%

0.0053

R5

5

7

71.4%

 
  1. * p calculated using Fischer's exact test
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us